Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
ACTIVE_NOT_RECRUITING
Status
Conditions
- Carcinoma, Ovarian Epithelial
- Ovarian Neoplasms
- Ovarian Cancer
- Ovarian Serous Adenocarcinoma
- Fallopian Tube Neoplasms
- Fallopian Tube Adenocarcinoma
- Fallopian Tube Serous Adenocarcinoma
- Peritoneal Cancer
- Peritoneal Carcinoma
- Peritoneal Neoplasms
Interventions
- BIOLOGICAL: Oregovomab
- DRUG: Paclitaxel
- DRUG: Carboplatin
- BIOLOGICAL: Placebo
- DRUG: Carboplatin
Sponsor
CanariaBio Inc.
Collaborators
- [object Object]
- [object Object]